 8. Has not recovered i.e., Grade 1 or at baseline from adverse events due to a previously administered agent. Note: Subjects with Grade 2 neuropathy are an exception to this criterion and may qualify for the study. If subject received major surgery, they must have recovered adequately from the toxicity andor complications from the intervention prior to starting therapy. 